Pullar Christine E, Isseroff R Rivkah
Department of Dermatology, University of California, Davis, CA 95616, USA.
J Cell Sci. 2005 May 1;118(Pt 9):2023-34. doi: 10.1242/jcs.02330. Epub 2005 Apr 19.
Re-epithelialization of wounded skin is necessary for wound closure and restoration of barrier function and requires directional keratinocyte migration towards the center of the wound. The electric field (EF) generated immediately upon wounding could be the earliest signal keratinocytes receive to initiate directional migration and healing. Keratinocytes express many beta2-adrenergic receptors (beta2-ARs), but their role in the epidermis is unknown. We have previously shown that beta-AR agonists decrease keratinocyte migration in a cyclic AMP (cAMP) independent mechanism involving the activation of protein phosphatase 2A (PP2A). Here, we ask whether beta2-ARs play a role in keratinocyte galvanotaxis. We report a bimodal response. When keratinocytes were exposed to higher concentrations of beta-AR agonist (0.1 microM), their tracked migratory speed was inhibited, in both the presence (directional migration) and the absence (random migration) of a 100 mV mm(-1) EF, as expected. At lower agonist concentrations (0.1 pM to 0.1 nM), there was no effect on migratory speed; however, all directionality was lost - essentially, cells were 'blinded' to the directional cue. Preincubating the cells with beta-antagonist restored directional migration, demonstrating that the 'blindness' was beta2-AR mediated. Incubation of keratinocytes with agents known to increase intracellular cAMP levels, such as sp-cAMP, pertussis toxin and forskolin, resulted in similar 'blinding' to the EF, whereas random migration was unaffected. The inactive cAMP analog rp-cAMP had no effect on keratinocyte migration, whether directional or random. However, rp-cAMP pretreatment before beta-agonist addition fully restored galvanotaxis, demonstrating the complete cAMP dependence of the attenuation of keratinocyte directional migration. This is the first report that cAMP is capable of mediating keratinocyte galvanotaxis. beta-AR agonists and antagonists could be valuable tools for modulating re-epithelialization, an essential step in the wound-healing process. Thus, beta-ARs regulate the two distinct components of keratinocyte directional migration differently: migration speed via a cAMP-independent mechanism and galvanotaxis by a cAMP-dependent one.
伤口皮肤的重新上皮化对于伤口闭合和屏障功能的恢复是必要的,并且需要角质形成细胞向伤口中心进行定向迁移。受伤后立即产生的电场(EF)可能是角质形成细胞接收到的启动定向迁移和愈合的最早信号。角质形成细胞表达许多β2 - 肾上腺素能受体(β2 - ARs),但其在表皮中的作用尚不清楚。我们之前已经表明,β - AR激动剂以一种不依赖环磷酸腺苷(cAMP)的机制减少角质形成细胞迁移,该机制涉及蛋白磷酸酶2A(PP2A)的激活。在此,我们探究β2 - ARs在角质形成细胞电趋性中是否起作用。我们报告了一种双峰反应。当角质形成细胞暴露于较高浓度的β - AR激动剂(0.1微摩尔)时,正如预期的那样,在存在100毫伏/毫米(-1)EF(定向迁移)和不存在EF(随机迁移)的情况下,其追踪的迁移速度均受到抑制。在较低的激动剂浓度(0.1皮摩尔至0.1纳摩尔)下,对迁移速度没有影响;然而,所有的方向性都丧失了——基本上,细胞对定向线索“视而不见”。用β - 拮抗剂预孵育细胞可恢复定向迁移,表明这种“失明”是由β2 - AR介导的。用已知可增加细胞内cAMP水平的试剂(如sp - cAMP、百日咳毒素和福斯高林)孵育角质形成细胞,会导致对EF产生类似的“失明”,而随机迁移不受影响。无活性的cAMP类似物rp - cAMP对角质形成细胞迁移(无论是定向还是随机)均无影响。然而,在添加β - 激动剂之前用rp - cAMP预处理可完全恢复电趋性,表明角质形成细胞定向迁移减弱完全依赖于cAMP。这是关于cAMP能够介导角质形成细胞电趋性的首次报道。β - AR激动剂和拮抗剂可能是调节重新上皮化的有价值工具,重新上皮化是伤口愈合过程中的一个关键步骤。因此,β - ARs以不同方式调节角质形成细胞定向迁移的两个不同组成部分:通过不依赖cAMP的机制调节迁移速度,通过依赖cAMP的机制调节电趋性。